NDC 51407-271

Aspirin and Extended-Release Dipyridamole

Aspirin And Extended-release Dipyridamole

Aspirin and Extended-Release Dipyridamole is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Golden State Medical Supply, Inc.. The primary component is Aspirin; Dipyridamole.

Product ID51407-271_924c340e-ca2e-1904-e053-2995a90adc88
NDC51407-271
Product TypeHuman Prescription Drug
Proprietary NameAspirin and Extended-Release Dipyridamole
Generic NameAspirin And Extended-release Dipyridamole
Dosage FormCapsule, Extended Release
Route of AdministrationORAL
Marketing Start Date2019-03-20
Marketing CategoryANDA / ANDA
Application NumberANDA204552
Labeler NameGolden State Medical Supply, Inc.
Substance NameASPIRIN; DIPYRIDAMOLE
Active Ingredient Strength25 mg/1; mg/1
Pharm ClassesPlatelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 51407-271-60

60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51407-271-60)
Marketing Start Date2019-08-22
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51407-271-60 [51407027160]

Aspirin and Extended-Release Dipyridamole CAPSULE, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA204552
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-08-22

Drug Details

Active Ingredients

IngredientStrength
ASPIRIN25 mg/1

OpenFDA Data

SPL SET ID:924c391c-22ec-14f7-e053-2995a90a3601
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 259081
    • Pharm Class PE
  • Decreased Prostaglandin Production [PE]
  • Decreased Platelet Aggregation [PE]
    • PHarm Class EPC
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Platelet Aggregation Inhibitor [EPC]
    • NUI Code
  • N0000008832
  • N0000008836
  • N0000175721
  • N0000000160
  • N0000175578
  • N0000175722

    • Pharmacological Class

    • Platelet Aggregation Inhibitor [EPC]
    • Decreased Platelet Aggregation [PE]
    • Cyclooxygenase Inhibitors [MoA]
    • Decreased Prostaglandin Production [PE]
    • Anti-Inflammatory Agents
    • Non-Steroidal [CS]
    • Nonsteroidal Anti-inflammatory Drug [EPC]

    NDC Crossover Matching brand name "Aspirin and Extended-Release Dipyridamole" or generic name "Aspirin And Extended-release Dipyridamole"

    NDCBrand NameGeneric Name
    42291-116Aspirin and Extended-Release DipyridamoleAspirin and Extended-Release Dipyridamole
    42571-274ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLEASPIRIN and Extended-Release DIPYRIDAMOLE
    51407-271Aspirin and Extended-Release DipyridamoleAspirin and Extended-Release Dipyridamole
    60687-305Aspirin and Extended-Release DipyridamoleAspirin and Extended-Release Dipyridamole
    62175-330Aspirin and Extended-Release DipyridamoleAspirin and Extended-Release Dipyridamole
    62559-850Aspirin and Extended-Release DipyridamoleAspirin and Extended-Release Dipyridamole
    65162-596Aspirin and Extended-Release DipyridamoleAspirin and Extended-Release Dipyridamole
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.